We support customers and community groups by sharing our market insights, research and thought leadership through the NAB Charitable Giving Index.
For research that provides a deeper understanding of the key drivers of mental health and wellbeing.
The Black Dog Institute
Depression and anxiety affect the lives of many Australians - one in six will experience depression and one in four will experience an anxiety disorder during their lifetime. Unfortunately, around 60 per cent of those with anxiety and depression do not seek or receive appropriate treatment. Left untreated, these illnesses lower quality of life, increase risk of suicide and worsen outcomes for other physical and mental health issues.
The Black Dog Institute aims to significantly reduce the incidence of mental illness and suicide, reduce the stigma surrounding mental health problems and empower all people to live the most mentally healthy life possible.
The NAB Foundation is helping to fund the Black Dog Institute’s first of a kind pilot project that integrates mental healthcare into GP clinics through an online platform that supports cost-effective accessible screening, early intervention, treatment and follow-up for those experiencing anxiety and depression.
The aim of this project is to evaluate an innovative system of individualised stepped mental health care that could ultimately be implemented throughout general practice clinics right across Australia.
Garvan Institute of Medical Research
The Garvan Institute of Medical Research’s mission is to make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human health. Garvan strives to enhance and develop research programs that combine fundamental science with strong clinical interaction.
The NAB Foundation’s grant is enabling the next stage of a neurogenomics project that aims to identify the genetic causes of bipolar disorder. Identifying the genes which carry damaging mutations will give researchers an understanding of the molecular basis of this severe psychiatric condition, helping to facilitating more effective diagnosis and personalised treatment. Potential discoveries may also lead to better understanding of other mental health disorders such as depression and schizophrenia.